Balanced news tone
News Sentiment
NATCOPHARM sentiment intelligence
NATCO Pharma Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
86/100 classification confidence.
directly relevant articles
high-authority source matches
+5.7% over one week, +13.9% over four weeks, trend inactive, and near fair-value range.
Natco Pharma gains nearly 3% on ₹2,500 crore South Africa investment plan
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Declining Stock and Solid Fundamentals: Is The Market Wrong About NATCO Pharma Limited (NSE:NATCOPHARM)?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Nov 2025 08:00
- Source
- simplywall.st
Natco Pharma shares jump over 4% after USFDA classifies Hyderabad facility as VAI
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Sep 2025 07:00
- Source
- Upstox
NATCO Pharma Limited's (NSE:NATCOPHARM) market cap dropped ₹6.6b last week; Individual investors bore the brunt
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Aug 2025 07:00
- Source
- simplywall.st
Why did Natco Pharma's share price slip 3% in trade today? Details here
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jun 2025 07:00
- Source
- Business Standard
Natco Pharma Share Price - Live NSE: NATCOPHARM Stock Price & Chart
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Mar 2024 22:34
- Source
- Upstox
NATCO Pharma Limited: Target Price Consensus and Analysts Recommendations | NATCOPHARM | INE987B01026
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 19 Aug 2020 17:10
- Source
- marketscreener.com